The US FDA‘s decision to revoke the 180-day exclusivity cover extended to Indian firm Ranbaxy to sell a generic version of the world‘s second-largest selling drug esomeprazole is likely to help rival Cipla, according to Vivek Kumar, research analyst, SBICap Securities.

Here are top 10 stocks to focus on January 27

Here are top 10 stocks to focus on January 27 - HDFC, Hindustan Unilever (HUL), Larsen and Toubro (L&T), Bharat Heavy Electricals (BHEL), Ultratech Cement, United Spirits, Shriram Transport, Bharat Electronics (BEL), Max India and Ranbaxy.

Buy Lupin 1500 call, Ranbaxy 700 Call: VK Sharma

VK Sharma of HDFC Securities recommends buying Lupin 1500 call and Ranbaxy Labs 700 Call.

Prefer pharma space, says Dilip Bhat

According to Dilip Bhat of Prabhudas Lilladher, one may bet on pharmaceutical space.

Sell UPL, buy Ranbaxy: Meghana Malkan

Meghana V Malkan of malkansview.com advises buying Ranbaxy with target of Rs 648.

Prefer pharma, underweight on IT: Dipan Mehta

Dipan Mehta, Member at BSE & NSE is of the view that one may prefer pharma stocks.

Here are top 10 stocks to focus on December 16

Here are top 10 stocks to focus on December 16 - Infosys, TVS Motor, Hindustan Petroleum Corporation Limited (HPCL), Indian Oil Corporation (IOC), State Bank of India (SBI), Punjab National Bank (PNB), Tata Power, Adani Power, Jaiprakash Associates and Hindustan Unilever (HUL).

Prefer banking, pharma stocks: Rahul Mohindar

Rahul Mohindar of viratechindia.com is of the view that one may prefer banking and pharma stocks.

Why you should buy Ranbaxy shares ahead of Sun acquisition

With the cloud of uncertainty vanishing from over the deal, traders can look to exploit an arbitrage opportunity between Sun and Ranbaxy shares.

See Sun-Ranbaxy divesting 7 brands by March: Surajit Pal

The Competition regulator has given a 6 month window for the divestment process, and only after the divestment is complete will the deal get the final nod. But Surajit Pal believes the divestment process should be done by March.

Here are top 10 stocks to focus on December 9

Here are top 10 stocks to keep an eye on December 9 - Idea Cellular, Opto Circuits, Karnataka Bank, Sun Pharma, Ranbaxy, Spicejet, OnMobile Global, Bajaj Finserv, Max India and Cadila Health.

Here are top 10 stocks to focus on December 4

Here are top 10 stocks to focus on December 4 - Ashok Leyland, Apollo Tyres, NBCC, HDFC Bank, ICICI Bank, MBL Infra, SAIL, Ranbaxy, Dr Reddy's and Sadbhav Engineering.

Here are top 10 stocks to keep an eye on November 20

Here are top 10 stocks to keep an eye on November 20 - Axis Bank, Wockhardt, DLF, Ranbaxy, Alok Industries, Kotak Mahindra Bank, ING Vysya, Hindalco, Jindal Steel and Pennar Industries.

Super Six intraday picks for the day

Meghana Malkan of malkansview.com suggests buying Ranbaxy Laboratories with a target of Rs 702-712 and UPL with a target of Rs 371-380.

Is Sun Pharma expensive at current valuations?

Purely from a short-term point of view there might not be too much of significant run up but purely on a fundamental basis Sun Pharma looks fairly strong, does warrant a presence in portfolios, has a fair amount of institutional investment as well, says Nipun Mehta.

Sun Pharma a must in core portfolio: Experts

Market experts Nipun Mehta and Dilip Bhatdo see no negatives for Sun Pharma if the Ranbaxy deal goes through.

Buy IRB Infra, Ranbaxy, Adani Ports: Vishal B Malkan

Vishal B Malkan of malkansview.com is of the view that one can buy Adani Ports for a target price of Rs 315 and Indiabulls Real Estate for a target price of Rs 82.

Bull's Eye: Buy Bharat Forge, Ashok Leyland, Ranbaxy Labs

Vishal B Malkan, malkansview.com advises buying IRB Infrastructure for a target price of Rs 285 and Ranbaxy Labs for a target price of Rs 720.

Buy IRB Infra, OBC, Ranbaxy Laboratories: Vishal Malkan

Vishal B Malkan of malkansview.com recommends buying Ranbaxy Laboratories for a target price of Rs 735 and Oriental Bank of Commerce for a target price of Rs 310.

Bull's Eye: Buy Bharat Forge, Titan, OBC, Ranbaxy Labs

Manav Chopra, Nirmal Bang advises buying Bharat Forge for a target price of Rs 870 and Adani Power for a target price of Rs 54.

Super Six: Top buying ideas for November 10

Meghana Malkan of malkansview.com advises buying Ranbaxy Laboratories with a target of Rs 690-710 and IRB Infrastructure Developers with a target of Rs 272-278.

Buy Ranbaxy Laboratories at lower level: Deven Choksey

Deven Choksey of KR Choksey Shares is of the view that one can buy Ranbaxy Laboratories at lower level.

Ranbaxy may suffer loss of $250 mn on approval woes: Expert

Surajit Pal, pharma analyst, Prabhudas Lilladher, expects Teva, Mylan, Sandoz and Dr Reddy‘s Laboratories to benefit from this loss.

Here are top 10 stocks to keep an eye on November 7

Here are top 10 stocks to keep an eye on November 7 - Ranbaxy, DLF, Bata, Cadila, Cummins, Ramco Cements, Ashok Leyland, Canara Bank, Escorts and HDFC Bank.

Invest in Ranbaxy Laboratories: Phani Sekhar

Phani Sekhar, Fund Manager-PMS at Angel Broking is of the view that one may invest in Ranbaxy Laboratories.